Frederick National Lab Site Map

Collapse HomeHome
Definition of NCI Organizations and Facilities in Frederick
Contracting at the Frederick National Lab
Leidos Biomedical Research, Inc.
Freedom of Information Act (FOIA)
For Academic Institutions
For Companies
For State and Local Governments
For NCI and NIH Staff
For Nonprofit Organizations
For Other Federal Agencies
ATP Site Not Found
Site Map
Collapse About Frederick National LabAbout Frederick National Lab
Advisory Committee
Contact Us
ATRF Directions
Locations (Accessible)
Privacy Policy
Highlighted Publications
Visitor's Guide
Office of the Directors
Federally Funded Research and Development Centers (FFRDC)
Collapse Careers and TrainingCareers and Training
Contractor Careers
Government Careers
Training and Education
Collapse Partnerships & CollaborationsPartnerships & Collaborations
Partnership Development Office (PDO)
New Partnership Agreement to Streamline Research
Business Mechanisms
Advanced Technology Research Facility (ATRF)
ATRF Partnering Space
Animal Sciences
Biomedical Computing
Cancer Biology
Clinical Research
Genetics & Genomics
Proteins & Proteomics
Structural Biology
Technology Development
CAPR Available Preclinical Cancer Models
NExT Program
Partnership Accomplishments
Pre-Approved Technical Services
FNLCR Services
Available Capabilities
Collapse ScienceScience
Collapse Laboratory Animal Science ProgramLaboratory Animal Science Program
Speed Congenics
Small Animal Imaging
Transgenic Mouse Model
Pathology and Histotechnology
Animal Sciences
Biomedical Computing
Drug Discovery & Development
Clinical Research
Molecular Technique
Molecular Diagnostics
Pharmaceutical Development
Structural Biology
CCR Virology
Collapse Optical Microscopy and Analysis Laboratory (OMAL)Optical Microscopy and Analysis Laboratory (OMAL)
OMAL Capabilities
OMAL Collaborations
OMAL Protocols and Resources
OMAL Fluorescence Resonance Energy Transfer (FRET)
OMAL Fluorescence Recovery After Photobleaching (FRAP)
OMAL Calcium Assays
OMAL Technology Development
OMAL Recent Publications
Image Gallery
OMAL Contacts
Collapse AIDS and Cancer Virus Program (ACVP)AIDS and Cancer Virus Program (ACVP)
ACVP Contacts
ACVP Capabilities
ACVP Recent Publications
ACVP Methods and Protocols
Quantitative Molecular Diagnostics Core
HIV Molecular Monitoring Core
Biological Products Core
Retroviral Protein Chemistry Core
Specimen Support Core
Cellular Immunity Core
Tissue Analysis Core
Viral Evolution Core
Retroviral Evolution Section
Retroviral Immunopathology Section
Retroviral Immunology Section
Retrovirus-Cell Interaction Section
Retroviral Pathogenesis Section
Viral Oncology Section
Collapse Protein Expression Laboratory (PEL)Protein Expression Laboratory (PEL)
PEL Capabilities
PEL Protocols and Resources
PEL Technology Development
PEL Publications
PEL Lab Contacts
PEL Combinatorial Cloning Platform
PEL Development of a multiplex onco-panel
PEL Improvements
PEL Improvements to Baculovirus Expression
PEL System Evaluation and Optimization
Collapse FNLCR ServicesFNLCR Services
Animal Services
Electron Microscopy
Nucleic Acid Technologies
HIV/SIV Capabilities
Nanotechnology Characterization
Optical Microscopy
Pre-clinical and Clinical Assays
Proteomics and Analytical Technologies
Protein Chemistry
Protein Expression
Tumor Repository
Available Capabilities
Collapse Vendor InformatonVendor Informaton
Collapse News & MultimediaNews & Multimedia
Collapse ArchiveArchive
Scientific Publications
BDP Supports First-in-Human Clinical Trials
CRADAs: They’re Not Just for NCI Anymore
NIH Director’s Award Recognizes Rapid Response to Avert Potential Health Crisis
McCormick to Aid FNLCR in Developing RAS Cancer Genetics Initiative
NCI Advisory Boards Give Green Light to Ras Initiative
NCL Collaborates with Army to Develop Botulism Vaccine
Partnership to Explore New Drug Combination for Pancreatic Cancer
Novel Vaccine Approach Achieves Functional Cure of AIDS Virus in Monkeys
One Dose of HPV Vaccine May Protect against Cervical Cancer
The Visiting Scholars Program
Videos Highlighting the People and the Mission of the FNLCR
RAS at the Frederick National Laboratory for Cancer Research
Gut Microorganisms Found Necessary for Successful Cancer Therapy
New Animal Model Could Boost Research on AIDS Drugs and Vaccines
New Mouse Model May Aid in Developing Effective Therapies for Ovarian Cancer
Rare Variant in POT1 Identified in Familial Melanoma Cases
Biomarkers in the Bloodstream May Foretell Risk of Lung Cancer
Experimental Vaccine for Mosquito-Borne Chikungunya Virus Rates Well in Clinical Study
Representative John Delaney Visited the FNLCR
New Genetic Markers Point to Increased Risk of Prostate Cancer
Experimental Lung Cancer Drug Shows Early Promise
FDA Approves Immunotherapy for a Cancer that Affects Infants and Children
New Breed of Mice May Improve Accuracy for Preclinical Testing of Cancer Drugs
FNL Scientists and Collaborators Solve 3-D Structure of Key Protein in Alzheimer’s Disease
Lab Plays Central Role in Groundbreaking National Clinical Trial in Precision Medicine
Crystal Structure of Protein Reveals Target for Drugs Against Lethal MERS Virus
Girls in Technology Essay Contest Winner Spends a Day in the Life of a Scientist
European Nanotechnology Experts Visit NCL; Harmonize Best Practices for Nanomedicine Collaboration in Europe
RAS Symposium Draws Hundreds of Attendees
Natural Product Shows Effectiveness in Combating Colorectal Cancer
FNLCR Collaborates with Moffitt Cancer Center on HPV and Oral Cancer
Collaboration with Pharma Will Introduce Nanotechnologies in Early Stage Drug Development
Targeting Hidden Reservoirs of the AIDS Virus for Eradication
Innovation Enables New Research on Mutation Linked to Many Cancers
FDA Accelerates Testing and Review of Experimental Brain Cancer Drug
Zika Phase 1 Clinical Trial Material—From Research to Release in 90 Days
Frederick National Lab Aids Liberian Hospitals Through Project C.U.R.E.
Leidos Biomed Teams with NCI, DOE, and Argonne National Lab to Support National X-Ray Resource
Eric Stahlberg Named to FCW’s Federal 100
Leidos Biomed Supports Clinical Trials for Vaccine Against Mosquito-borne Chikungunya
Study Provides Additional Evidence for the Effectiveness of Green Tea in Preventing Colon Cancer